Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Failed Trodelvy first-line NSCLC trial shows better China data
Trodelvy-Keytruda showed a negative overall survival signal over Keytruda in the global phase 3 trial but a 35% positive trend in Chinese patients.
Angus Liu
Sep 12, 2026 9:45pm
AstraZeneca’s Etcamah flunks first-line breast cancer trial
Sep 12, 2026 12:43pm
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
Handa's Cabometyx formulation no threat to Exelixis: analysts
Sep 11, 2026 2:06pm
Pharma marketers face privacy hurdles, turn to omnichannel strategies
Brought to you by
Swoop
The Oral GLP-1 Tracker: Novo, Lilly obesity pills grow scripts
Sep 11, 2026 10:15am
